Welcure Drugs Ltd. has unveiled plans for a share split alongside a bonus share issuance, marking a strategic move to improve liquidity and broaden shareholder participation. The company’s board approved a stock split and declared bonus shares to existing investors, aiming to make its shares more affordable and attractive in the secondary market. These corporate actions reflect Welcure Drugs’ commitment to optimizing capital structure while rewarding shareholders.